Myriad Genetics Inc. (MYGN) climbed in early trade Tuesday, but settled into a range for the majority of the session. The stock finished up by 0.99 at $34.10.
Myriad Genetics climbed to a new high for the year Tuesday, but is now down 0.85 on 92K shares after the bell.
For comments and feedback: editorial@rttnews.com